Centro de Cancer Emma Romero De Callejas

What Centro de Cancer Emma Romero De Callejas does

Centro de Cancer Emma Romero de Callejas (CCERC) is a nonprofit cancer treatment center headquartered in Tegucigalpa, Honduras, founded in 1990 and operational since 1991. It provides integrated oncological care across the full patient pathway — outpatient consultation in oncology, hematology, radio-oncology, gynecology, nuclear medicine, radiology, gastroenterology, palliative care, nutrition, and psychology — supported by a clinical laboratory offering 30+ tests, chemotherapy administration in 11 dedicated chairs, advanced radiotherapy via two linear accelerators with IMRT capability, robotic high-dose-rate brachytherapy (IR-192), and a broad nuclear medicine diagnostic and therapeutic program. Its core technology platform combines capital-intensive medical equipment that is exclusive in Honduras, including the BD FACS CANTO II flow cytometry system and GeneXpert Cepheid molecular diagnostic platform, with a Big Bore RT CT simulator for radiotherapy planning, and 3D Tomosynthesis mammography for breast cancer screening.

The center operates a direct-to-patient business model combining fee-for-service medical consultations, diagnostic services, treatment services, and on-site pharmacy dispensing, supplemented by donations accepted through bank accounts at BAC Honduras, BANHCAFE, and Banco Occidente, as well as an online donation portal managed through the Honduran Association for Cancer Fight (AHLCC). Its go-to-market relies on community medical brigades that have reached 298 Honduran municipalities, the annual Relay for Life fundraising event attracting approximately 4,000 participants, and content marketing through blog posts and patient testimonials. The facility is the only oncology center in Honduras offering flow cytometry and GeneXpert molecular diagnostics, and its multidisciplinary tumor committee and home-visit palliative care program provide integrated care continuity from diagnosis through end-of-life support.

Strategically, CCERC functions as a national referral hub for cancer care in Honduras, combining diagnostic exclusivity, multidisciplinary clinical talent, and community-wide outreach. Recent moves include a 2025 solar energy installation with Solaris to ensure operational continuity, a May 2025 50% mammography screening promotion to expand preventive-screening volume, and continued investment in equipment upgrades since the 2013 inauguration of its Teletherapy Center. The center is affiliated with the Asociación Hondureña de Lucha Contra el Cáncer, partnered with UNAH for medical education, and recognized internationally through Tulane University's recognition of Dr. Antonio Barrios for contributions to cancer care.

Name

Centro de Cancer Emma Romero De Callejas

Legal name

Centro de Cancer Emma Romero de Callejas

Website

https://centrodecancerhn.org

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Centro de Cancer Emma Romero de Callejas is a nonprofit oncology center in Tegucigalpa, Honduras, founded in 1990, providing integrated cancer diagnosis, treatment, and palliative care to Honduran patients through exclusive diagnostic technology and community-wide outreach.

Ownership category

akta.pro rank

Product category

Oncology Care Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

Keywords

• Cancer treatment services
• Oncology diagnostics
• Radiation therapy
• Clinical laboratory
• Palliative care

Headquarters

HQ city

Tegucigalpa

HQ country

Honduras

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Consultation Services: Outpatient consultations across multiple specialties including Oncology, Hematology, Radio-oncology, Gynecology, Nuclear Medicine, Radiology, Gastroenterology, General Medicine, Palliative Care, Nutrition, and Psychology
2. Diagnostic Services: Laboratory tests (tumor markers, reproductive hormones, immunology, molecular biology, flow cytometry, cytogenetics), imaging (X-ray, mammography, ultrasound, CT scan), nuclear medicine studies, endoscopy, and colposcopy
3. Treatment Services: Chemotherapy, radiotherapy (teletherapy and brachytherapy), iodine-131 therapy for hyperthyroidism and thyroid cancer
4. Pharmacy Services: Dispensing of high-quality ethical medications on-site
5. Donations and Charitable Contributions: Accepting donations through bank accounts (BAC Honduras, BANHCAFE, Banco Occidente) and online portal for supporting patient care and facility operations

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Centro de Cancer Emma Romero De Callejas is a non-profit cancer treatment institution in Honduras providing integrated oncology services, including diagnostic imaging (CT, ultrasound), clinical laboratory analysis, nuclear medicine, external beam radiotherapy, high-dose-rate brachytherapy, chemotherapy, gynecology-oncology consultation, and palliative care for cancer patients. Established in 1990, it delivers these services to the Honduran population with a focus on accessibility through subsidized pricing and donations.

Product overview

Centro de Cancer Emma Romero de Callejas (CCERC) is a specialized cancer treatment center established in 1990 that operates as an integrated multi-service facility offering diagnosis and treatment services. The center provides a comprehensive portfolio of services including outpatient consultations across multiple specialties (Oncology, Hematology, Radio-oncology, Gynecology, Nuclear Medicine, Radiology, Gastroenterology, General Medicine), a full-service Clinical Laboratory with advanced Flow Cytometry and molecular biology capabilities, Chemotherapy with specialized safety equipment, Advanced Radiotherapy with dual Linear Accelerators and Brachytherapy, Nuclear Medicine diagnostics and therapies, Radiology and Imaging including digital mammography with 3D Tomosynthesis, CT scanning, Endoscopy services, Pharmacy, Nutrition, Psychology, Palliative Care, and Health Education programs. The center also hosts the Relevo por la Vida community fundraising event. All services are delivered through a multidisciplinary team approach aimed at providing personalized, high-quality oncology care in Honduras.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Diagnostics — CT Imaging CT-based diagnostic imaging used for cancer detection, staging, and treatment planning for patients referred to the oncology center.
• Oncology Diagnostics — Ultrasound Ultrasound imaging used for cancer assessment, particularly for abdominal, pelvic, and soft-tissue tumor evaluation in oncology patients.
• Clinical Laboratory Analysis Oncology-focused clinical laboratory tests including hematology, chemistry, tumor markers, cytology, and biopsy analysis to support cancer diagnosis and monitoring.
• Nuclear Medicine Services Nuclear medicine procedures (scintigraphy, bone scans, and radiopharmaceutical therapies) used for cancer staging, treatment response evaluation, and select targeted therapies.
• External Beam Radiotherapy External beam radiation therapy delivered using linear accelerator and cobalt-therapy units for curative and palliative treatment of solid tumors.
• High-Dose-Rate (HDR) Brachytherapy High-dose-rate internal radiation therapy (brachytherapy) primarily for gynecological cancers, providing localized radiotherapy via implanted radioactive sources.
• Chemotherapy Treatment Systemic chemotherapy administration to cancer patients, delivered as part of multi-disciplinary oncology treatment plans.
• Gynecology-Oncology Consultation Specialist consultative service for women diagnosed with gynecological cancers (cervical, ovarian, uterine), including treatment planning and follow-up.
• Psychological Support Services Psychological counseling and emotional support services provided to cancer patients and their families as part of the oncology care continuum.
• Palliative Care Palliative care services for cancer patients with advanced or terminal disease, focused on symptom management and quality of life.

Quantifiable outcome

• Complete laboratory diagnosis in 4 hours
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Asociación Hondureña de Lucha Contra el CáncercoreStrategic or Co-development Partner · 1 January 2003Local partner organizing the Relay for Life event in Honduras since 2003. This is a 24-hour fundraising event attracting 4,000+ participants including survivors, families, schools, government, civil society, and businesses. The center actively participates in this cancer awareness and fundraising initiative.
• UNAH (Universidad Nacional Autónoma de Honduras)minorStrategic or Co-development Partner · 1 January 2000University partnership established for medical education and training. Includes agreements for medical student education and rotations at the cancer center.
• American Cancer Society (Relay for Life)minorStrategic or Co-development Partner · 1 January 1985International organization behind the Relay for Life initiative. Started in 1985, it is now the world's largest fundraising event present in over 5,000 cities globally. The center participates in the Honduras chapter organized by AHLCC.
• SolariscoreStrategic or Co-development PartnerSolaris installed solar panels at the cancer center, enabling the facility to operate on clean energy. This initiative supports cost savings on electricity, allowing more resources to be directed to patient care. Critical areas including Radiotherapy, Tomography, and Clinical Laboratory can now operate more efficiently and continuously, even during electrical instability.

Scale indicators7 records

Recent moves7 records

Expansion highlights4 records

Regional players

• Hospital Oncológico de Panamá: Panama's dedicated cancer hospital; direct Central American comparator for a specialized cancer treatment center, providing chemotherapy, radiotherapy, and surgical oncology to a national catchment.
• Centro Médico Imbanaco: Colombian private oncology provider with advanced radiotherapy, nuclear medicine, and multi-specialty cancer care; comparable in offering integrated diagnostic and treatment services with sophisticated equipment, but operating in a more developed market.
• Liga Contra el Cáncer (Perú): Peruvian nonprofit focused on cancer prevention, screening, and patient support; comparable mission-driven model with community outreach and screening brigades, though more prevention-focused than clinical.
• Instituto Nacional de Cancerología (INCan Mexico): Mexico's national cancer institute offering full-spectrum oncology including radiation, chemotherapy, and palliative care; comparable operating model as a tertiary oncology referral center, though government-funded and at much larger scale.
• Hospital General San Felipe: Tegucigalpa-based Honduran public hospital that provides some oncology services; the closest same-country peer operating in a broader general hospital context rather than a dedicated cancer center.
• SOLCA (Sociedad de Lucha Contra el Cáncer): Ecuador's nonprofit cancer care network operating hospitals and screening programs; shares the nonprofit, brigade-driven, multi-service cancer center model with CCERC, but at a larger national scale.
• Instituto Nacional de Cancerología (INC Colombia): Colombia's national cancer institute providing comprehensive oncology diagnosis, treatment, and research; comparable in being a country-level referral center for hematology, radiotherapy, and complex oncology, though at significantly larger scale.

Others

• BD Biosciences: Manufacturer of the BD FACS CANTO II flow cytometry platform used by CCERC; not a competitor but a critical technology enabler whose product roadmap directly affects CCERC's hematological diagnostics capability.
• Elekta: Global manufacturer of linear accelerators and brachytherapy systems; economically linked to CCERC as a capital equipment vendor and a key enabler of the radiotherapy service line rather than a direct competitor.
• Varian Medical Systems (Siemens Healthineers): Leading supplier of linear accelerators, treatment planning, and oncology workflow software; a key infrastructure provider for ambulatory oncology centers like CCERC offering IMRT and brachytherapy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/centro-de-cancer-emma-romero-de-callejas

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro de Cancer Emma Romero De Callejas